Relmada Therapeutics (RLMD) Cash from Investing Activities (2014 - 2026)
Relmada Therapeutics (RLMD) reported Cash from Investing Activities of -$135.2 million for Q1 2026, down 980.4% year-over-year from $15.4 million in Q1 2025, and down 75.78% on a QoQ basis from -$76.9 million in Q4 2025.
Relmada Therapeutics (RLMD) has 13 years of Cash from Investing Activities data on file, last reported at -$135.2 million in Q1 2026.
- Quarterly Cash from Investing Activities fell 980.4% year-over-year to -$135.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$198.7 million (down 449.48% YoY) and the FY2025 annual result came in at -$48.1 million, down 193.36% from the prior year.
- Cash from Investing Activities fell to -$135.2 million in Q1 2026 per RLMD's latest filing, from -$76.9 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at $40.0 million in Q1 2023 and bottomed at -$135.2 million in Q1 2026.
- The 5-year median for Cash from Investing Activities is $6.8 million (2025), against an average of -$3.6 million.
- The widest annual swing landed in 2024, when Cash from Investing Activities soared 1316.79%; it then plunged 980.4% in 2026.
- Tracing RLMD's Cash from Investing Activities over 5 years: stood at -$1.7 million in 2022, then surged by 567.62% to $7.7 million in 2023, then jumped by 46.56% to $11.3 million in 2024, then tumbled by 778.07% to -$76.9 million in 2025, then slumped by 75.78% to -$135.2 million in 2026.
- Per Business Quant, the three latest RLMD Cash from Investing Activities figures stand at -$135.2 million (Q1 2026), -$76.9 million (Q4 2025), and $6.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -25.54 Mn |
| 10 | Relmada Therapeutics | 595.35 Mn | 595.35 Mn | - | -135.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -135.23 Mn |
| Mar 31, 2026 | -135.23 Mn |
| Dec 31, 2025 | -76.93 Mn |
| Dec 31, 2025 | -76.93 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.75 Mn |
| Jun 30, 2025 | 6.68 Mn |
| Jun 30, 2025 | 6.68 Mn |
| Mar 31, 2025 | 15.36 Mn |
| Mar 31, 2025 | 15.36 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Dec 31, 2024 | 11.35 Mn |
| Sep 30, 2024 | 16.14 Mn |
| Sep 30, 2024 | 16.14 Mn |
| Jun 30, 2024 | 14.01 Mn |
| Jun 30, 2024 | 14.01 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Mar 31, 2024 | 10.06 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Dec 31, 2023 | 7.74 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Sep 30, 2023 | 3.86 Mn |
| Jun 30, 2023 | -1.15 Mn |
| Jun 30, 2023 | -1.15 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Mar 31, 2023 | 40.00 Mn |
| Dec 31, 2022 | -1.66 Mn |
| Dec 31, 2022 | -1.66 Mn |
| Sep 30, 2022 | 31.56 Mn |
| Sep 30, 2022 | 31.56 Mn |
| Jun 30, 2022 | -140,520.00 |
| Jun 30, 2022 | -140,520.00 |
| Mar 31, 2022 | -10.03 Mn |
| Mar 31, 2022 | -10.03 Mn |
| Dec 31, 2021 | -91.18 Mn |
| Dec 31, 2021 | -91.18 Mn |
| Sep 30, 2021 | 27.51 Mn |
| Sep 30, 2021 | 27.51 Mn |
| Jun 30, 2021 | -5.91 Mn |
| Jun 30, 2021 | -5.91 Mn |
| Mar 31, 2021 | 15.47 Mn |
| Mar 31, 2021 | 15.47 Mn |
| Dec 31, 2020 | 935,278.00 |
| Dec 31, 2020 | 935,278.00 |
| Sep 30, 2020 | 4.59 Mn |
| Sep 30, 2020 | 4.59 Mn |
| Jun 30, 2020 | -16.34 Mn |
| Jun 30, 2020 | -16.34 Mn |
| Mar 31, 2020 | -23.63 Mn |
| Mar 31, 2020 | -23.63 Mn |
| Dec 31, 2019 | -80.16 Mn |
| Dec 31, 2019 | -80.16 Mn |
| Jun 30, 2018 | -9,800.00 |
| Jun 30, 2018 | -9,800.00 |
| Sep 30, 2017 | -2,591.00 |
| Sep 30, 2017 | -2,591.00 |
| Jun 30, 2017 | -2,202.00 |
| Jun 30, 2017 | -2,202.00 |
| Mar 31, 2017 | -20,227.00 |
| Mar 31, 2017 | -20,227.00 |
| Dec 31, 2016 | -2,434.00 |
| Dec 31, 2016 | -2,434.00 |
| Sep 30, 2016 | -24,827.00 |
| Sep 30, 2016 | -24,827.00 |
| Jun 30, 2016 | -23,043.00 |
| Jun 30, 2016 | -23,043.00 |
| Mar 31, 2016 | -63,108.00 |
| Mar 31, 2016 | -63,108.00 |
| Dec 31, 2015 | -474,795.00 |
| Dec 31, 2015 | -474,795.00 |
| Sep 30, 2015 | -1,310.00 |
| Sep 30, 2015 | -1,310.00 |
| Jun 30, 2015 | -3,870.00 |
| Jun 30, 2015 | -3,870.00 |
| Mar 31, 2015 | -2,286.00 |
| Mar 31, 2015 | -2,286.00 |
| Dec 31, 2014 | -6,500.00 |
| Dec 31, 2014 | -6,500.00 |
| Sep 30, 2014 | -10,670.00 |
| Sep 30, 2014 | -10,670.00 |
| Jun 30, 2014 | -3,673.00 |
| Jun 30, 2014 | -3,673.00 |
| Mar 31, 2014 | -9,470.00 |
| Mar 31, 2014 | -9,470.00 |